Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Quickly dividing cells" is not a specific molecule or receptor but rather a descriptive term for any population of cells undergoing frequent and rapid division. This includes both normal physiological contexts—such as skin regeneration, wound healing, and tissue growth—and pathological contexts like cancer. In oncology and pharmacology, the phrase often refers to tumor cells that proliferate uncontrollably; however, it also encompasses healthy tissues with high turnover rates such as bone marrow progenitors and intestinal epithelial cells[3][6]. Therapeutically targeting "quickly dividing cells" is a foundational principle behind many anticancer drugs. These agents exploit the higher mitotic rate of tumor versus most normal tissues by interfering with DNA synthesis or mitosis. However, because some healthy tissues also divide quickly under normal conditions (for example during hematopoiesis or mucosal renewal), these treatments are associated with significant side effects due to lack of specificity[4][6]. Because "quickly dividing cell" does not refer to a single molecular entity but rather a functional state shared by diverse cell types across multiple lineages and organisms—including bacteria like *E. coli* that can double every 20 minutes—it cannot be classified within standard molecular target families such as receptors or enzymes[2][5]. Instead, it describes cellular behavior relevant for understanding disease mechanisms (notably cancer) and therapeutic strategies. In summary: > The term "quickly dividing cell" is **not** a canonical molecular target but an operational description used in biology and medicine for populations characterized by high rates of proliferation. It lacks specificity at the level required for structured drug-target databases. Therefore, - **is_target:** false — this is not considered a discrete therapeutic target. - **is_incorrect:** true — this entry does not correspond to an individual molecule/receptor suitable for structured annotation per your conventions.
Inhibition of DNA replication or mitosis to prevent proliferation of rapidly dividing cells (as with many chemotherapeutic drugs)[4]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Quickly dividing cell (null).